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Abstract 
 
Protein encapsulated gold nanoclusters have received much attention due to the possibility of using them as a 
non-toxic fluorescent probe or marker for biomedical applications, however one major disadvantage currently 
is their low brightness and quantum yield in comparison to currently used fluorescent markers. A method of 
increasing the fluorescence emission of Human Serum Albumin (HSA) encapsulated gold nanoclusters (AuNCs) 
via a Polyallylamide hydrochloride (PAH) coating is described. PAH molecules with a molecular weight of ~17,500 
Da were found to enhance the fluorescence emission of HSA-AuNCs by 3-fold when the protein/polymer 
concentration ratio is 2:1 in solution. Interestingly, the fluorescence lifetime of the AuNCs was found to decrease 
while the native tryptophan (TRP) fluorescence lifetime also decreased during the fluorescence emission 
intensity enhancement caused by the PAH binding. Coinciding with the decrease in fluorescence lifetime, the 
zeta potential of the system was observed to be zero during maximum fluorescence intensity enhancement, 
causing the formation of large aggregates. These results suggest that PAH binds to the HSA-AuNCs acting as a 
linker; causing aggregation and rigidification, which results in a decrease in separation between native TRP of 
HSA and AuNCs; improving Förster Resonance Energy Transfer (FRET) and increasing the fluorescence emission 
intensity. These findings are critical to the development of brighter protein encapsulated AuNCs. 
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Introduction 
 
Several studies have been undertaken to understand the unique fluorescent properties of protein encapsulated 
gold nanoclusters (AuNCs)[1–3]. Their red band emission peak, non-toxicity and non-photobleaching nature 
make them perfectly suited for biological imaging and sensing[4,5]. However, in their current state protein 
encapsulated AuNCs have very low brightness levels, with quantum yields reported at ~6 %[6]. Of all the protein 
encapsulated AuNCs which have been synthesised, human serum albumin (HSA) AuNCs have received the most 
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attention[7–11]. Serum albumin is the most abundant protein found in mammalian blood, acting as a 
transportation molecule for a variety of molecules including drugs, thus much research has been undertaken to 
fully understand the protein characteristics in different environments and conditions[12–17]. Previous research 
on the native protein offers insights as to why HSA encapsulated AuNC fluorescence characteristics change in 
differing environments.   Previously it has been shown that the fluorescence emission of HSA-AuNCs is quenched 
in low pH solutions due to the exposure of AuNCs to the solvent as the HSA protein unfolds[18]. The 
physicochemical characteristics of HSA-AuNCs has also been studied to understand the effects AuNCs synthesis 
has on the proteins natural characteristics[19]. Of major interest was the large shift in the protein’s surface 
charge to a highly negative charge state at neutral pH values and lends itself to the possibility that positively 
charged molecules can be bound to the surface; allowing for the modification of the HSA-AuNCs, enhancing the 
fluorescence emission brightness.  Fan et. al. successfully enhanced the fluorescence emission brightness of 
CdSeS/ZnS quantum dots by 2 orders of magnitude via a PMMA-co-MMA polymer[20]. To explore these 
enhancements a positively charged polymer, polyallylamine hydrochloride (PAH), was chosen as a means of 
coating due to the negative surface charge of the HSA-AuNC complex. PAH is typically used as a means of creating 
a highly hydrophobic film in conjunction with polysodium styrene sulfonate (PSS), forming a layer by layer 
negatively and positively charged film, which is typically used in microencapsulation of molecules and 
nanoparticles[21,22]. 
Materials and Methods 
 
HSA-AuNCs were synthesised using the commonly cited one-pot method developed by Xie et. al.[23]. 17 mg of 
HAuCl4 and 250 mg of HSA were dissolved separately in two beakers with 5 ml of water at 37 °C. Once dissolved 
the two solutions were mixed together for 2 mins. Next 0.5 ml of NaOH at a concentration of 1 M was added to 
the mixture, increasing the pH above 10. The solution was then stirred and kept at a constant 37 °C for 6 hours. 
After 6 hours the sample was then kept at 37 °C in an oven for 24 hrs. The concentrated solution was then 
purified after synthesis using 10 kDa dialysis cassettes. Dialysis was carried out in a PBS buffer solution (I = 0.01 
M, pH = 7.4). The dialysed HSA-AuNCs solution was diluted to 40 M with PBS buffer solution (I = 0.01 M, pH = 
7.4) for use during all fluorescence based experiments. A stock solution of PAH (Mw = 17,500 Da) was prepared 
at a concentration of 1 mM for use in all fluorescence based experiments. For Zeta potential and Dynamic Light 
Scattering (DLS) experiments, the concentration of HSA-AuNCs and PAH stock concentration were diluted by 
37.5 % to 15.0 µM and 375 µM, respectively. All chemicals were purchased from Sigma Aldrich. Fluorescence 
emission data was collected using a Horiba Fluorolog 3. Fluorescence lifetime data was collected using a Horiba 
Deltaflex. All experiments carried out on the Horiba Deltaflex were carried out using a NanoLED pulsed light 
source (excitation wavelength 295 nm). A Time-to-amplitude converter (TAC) range of 100 ns was used to study 
tryptophan (TRP) fluorescence lifetimes, a TAC range of 13 s was used for AuNCs fluorescence lifetimes. 
Dynamic Light Scattering (DLS) and electrophoretic mobility experiments were carried out on a Malvern 
Zetasizer NS. UV-Vis measurements were carried out on a Thermofisher Evolution 201 Spectrophotometer. 
Results and Discussion 
 
To illustrate the maximum fluorescence enhancement of HSA-AuNCs after adding a polymer coating the 
emission spectra for native HSA-AuNCs and HSA-AuNCs with PAH added (HSA-AuNCs-PAH) excited at 290 nm 
and 470 nm are shown in Figure 1.  
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The fluorescence spectrum of HSA-AuNCs after the 20 M PAH coating when exciting at 290 nm can be seen to 
increase 3-fold while the emission peak position is slightly redshifted by 8 nm. When directly exciting the AuNC 
using 470 nm excitation a fluorescence enhancement is also evident however it is not as substantial as exciting 
at 290 nm where the AuNC is excited predominately via a Forster Resonance Energy Transfer (FRET) from the 
single TRP of HSA to the AuNC[9,18]. To find the best ratio of PAH:HSA-AuNCs, small additions of PAH were made 
to a solution of HSA-AuNCs and the maximum emission intensity for both excitation at 290 nm and 470 nm were 
measured, as shown in Figure 2.  
 
From Figure 2 we can see that the addition of PAH coating to HSA-AuNCs results in a gradual increase in 
fluorescence emission from the AuNCs until a maximum is reached at a concentration of 20 M of PAH and it 
returns to the original fluorescence intensity at 40 M. The fluorescence enhancement when exciting at 290 nm 
Figure 1. Fluorescence emission spectra of HSA-AuNCs without PAH coating and HSA-AuNCs with 20 
M PAH coating. Excitation wavelength of 290 nm and 470 nm. 
Figure 2. Maximum emission intensity of HSA-AuNCs as a function of added PAH concentration. Peak emission 
intensity for 290 nm excitation (black), 470 nm (red). HSA-AuNCs concentration is kept at a concentration of 
40.0 M throughout. Vertical red lines indicate the molecular ratio between PAH:HSA-AuNCs. 
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can be explained by an improvement in the FRET process due to the coating of the HSA-AuNC with PAH causing 
a change in conformation that may bring the TRP and AuNC closer together enhancing the FRET[24–27].  
However, no FRET takes place at 470 nm excitation and a different enhancement mechanism must be 
responsible for the increase in intensity observed. A decrease in collisional quenching due to the PAH shielding 
the HSA-AuNC complex from solution may account for fluorescence intensity enhancement. Another possibility 
is the AuNC is rigidified by the PAH interaction, causing an increase in emission via the Au(I) shell[28].  Increasing 
the PAH concentration from 40 M to 200 M resulted in no further changes to the fluorescence emission 
intensity when exciting at 290 nm and 470 nm. Changes to the peak emission wavelength were also observed 
upon the addition of PAH to a HSA-AuNC solution, as shown in Figure 3. 
 
 A red shift in the peak emission wavelength of 10 nm when excited at 290 nm and a red shift of 5 nm when 
excited at 470 nm was observed. The red shift may be explained by changes in the TRP microenvironment 
brought about by PAH interactions. The red shift of TRP results in a reduced spectral overlap between TRP 
emission and AuNC absorption. Therefore, improved FRET must arise from a reduced donor-acceptor pair 
separation. The maximum emission intensity of TRP was also monitored while adding PAH, shown in Figure 4.  
 
Figure 3. Peak emission wavelength of tryptophan fluorescence from HSA-AuNCs as a function of PAH 
concentration in solution. Excitation wavelength 290 nm. 
Figure 4. Maximum emission intensity of tryptophan fluorescence from HSA-AuNCs as a function of PAH concentration in 
solution. Excitation wavelength 290 nm. 
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 The maximum fluorescence intensity of TRP was observed to decrease (as AuNC emission increased), as a result 
of increased PAH concentration. This decrease in TRP fluorescence intensity is an indicator of increased FRET 
efficiency. It is possible that the decrease is  also linked to a decrease in quantum yield of TRP due to the presence 
of the positively charged PAH nearby affecting the electron transfer between the TRP indole ring and acceptor 
during fluorescence[29]. However, a decrease in donor quantum yield would result in a decrease in FRET 
efficiency. Therefore the improvement in FRET efficiency observed here may be dominated by the decrease in 
the donor-acceptor separation. Fluorescence lifetime measurements of the AuNC and TRP  were both taken and 
3 exponential fittings were used to describe best the fluorescence lifetime decays measured for TRP  and AuNC 
emission as previous studies [18,30]. The fluorescence decay of AuNCs consists of two s duration fluorescence 
lifetimes arising from AuNC emission and one shorter lifetime resulting from scattered light. The fluorescence 
decay of TRP consists of three ns duration fluorescence lifetimes arising from 3 different rotamer forms of the 
TRP residue, as shown in Table 1.  
Table 1. Fluorescence lifetimes and relative amplitudes of the fluorescence decays associated of TRP and AuNCs 
with different concentrations of PAH added. 
Emission. Source        
(PAH concentration) 
τ1 ns      
(rel. amp) 
τ2 ns       
(rel. amp) 
τ3 ns           
(rel. amp) 
χ2 
TRP (0 µM PAH) 1.05±0.05 
(47.13 %) 
2.89±0.51 
(4.90 %) 
5.78±0.20 
(17.98 %) 
1.45 
TRP (20 µM PAH) 0.08±0.01 
(85.10 %) 
1.55±0.27 
(8.17 %) 
3.75±0.33 
(6.73 %) 
1.48 
TRP (40 µM PAH) 0.27±0.07 
(99.86 %) 
1.52±0.02 
(0.11 %) 
4.27±0.30  
(0.03 %) 
1.71 
AuNC (0 µM PAH) 100±30 
(7.01 %) 
1020±140 
(26.17 %) 
2220±40  
(66.82 %) 
1.73 
AuNC (20 µM PAH) 20±20 
(2.00 %) 
130±80 
(6.01 %) 
1430±240 
(92.99 %) 
1.37 
AuNC (40 µM PAH) 60±40 
(7.66 %) 
1040±290 
(30.79 %) 
2250±90  
(61.55 %) 
1.51 
 
The high χ2 values of the fittings are possibility due to the high amount of light scattering experienced due to 
AuNCs and particle aggregation. The initial fluorescence lifetimes of 1.02 and 2.22 s observed before adding 
PAH to the HSA-AuNC solution were consistent with previous studies[18]. Upon adding 20 M of PAH, the 
fluorescence lifetimes of AuNCs was seen change dramatically, with one lifetime of 1.43 s becoming the 
dominant fluorescence source with a relative amplitude of 92.99 %. The other shorter fluorescence lifetimes are 
attributed to scattered light. The decrease in fluorescence lifetime while intensity increases indicate that the 
fluorescence enhancement is not caused by reduced collisional quenching and is more likely due to the 
rigidification mechanism previously reported[28]. A decreasing lifetime in conjunction with an increasing 
fluorescence intensity was also previously observed when adding native Lysozyme to Ly-AuNCs, which was 
attributed to aggregation and changes to the complexes’ conformation[31]. Upon increasing the PAH 
concentration to 40 M, the fluorescence lifetimes were seen to return to their previous state. Before adding 
PAH to the HSA-AuNC solution, the TRP fluorescence has 3 fluorescence lifetimes. Upon adding 20 M of PAH 
the lifetimes become shorter; the two longer lifetimes decrease to 1.55 and 3.75 ns, with the shorter lifetime of 
0.08 ns becoming dominant with a relative amplitude of 85.10 %. Upon increasing the PAH concentration 
further, the shorter fluorescence lifetime becomes even more dominant with 99.86 %, however the values of 
the 2 longer fluorescence lifetimes do not change. When TRP becomes exposed to water, its fluorescence 
lifetime decay curve has been shown to change from having 3 exponential fluorescence dynamics to 2 
exponential fluorescence dynamics; with the 2 lifetimes being the same duration as the 2 longer fluorescence 
lifetimes observed[32].  The changes to the fluorescence lifetime of TRP may indicate a change in the protein 
conformation upon PAH interaction. The third shorter lifetime seen when adding PAH can be explained by the 
PAH coating increasing the particle size of HSA-AuNCs and thus more effectively scattering light. This is 
supported by the shorter fluorescence lifetime’s relative amplitude increasing upon the addition of further PAH. 
To further understand the physical changes which PAH addition induces to HSA-AuNCs, the particle size and zeta 
potential of the HSA-AuNC solution while adding PAH was determined. The particle size of HSA-AuNCs were seen 
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reach a peak size when the HSA-AuNC fluorescence emission is at a maximum and then decrease with a further 
increase in the PAH concentration to the solution, as shown in Figure 5.  
 
Interestingly, the largest complex sizes were observed when the overall zeta potential of the solution complex 
was near zero, as shown in Figure 6.  
 
From the diameter and zeta potential results we can clearly see that the enhancement of fluorescence emission 
from HSA-AuNCs coincides with an increase in the complex aggregate diameter which results from a lack of 
electrostatic repulsion between the HSA-AuNCs/PAH in solution, since the overall net charge of the solution at 
a 1:2 molecular ratio is close to zero. Previously we observed that a solution of HSA-AuNCs at pH 7.4 has a zeta 
potential of –30 mV[19]. The zeta potential of PAH at pH 7.4 was previously observed to be 30 mV due to partial 
Figure 5. The diameter of HSA-AuNCs/PAH complexes as a function of PAH concentration in solution. HSA-
AuNCs concentration is kept at a concentration of 7.50 µM throughout. Vertical red lines indicate the 
molecular ratio between PAH:HSA-AuNCs. 
Figure 6. The zeta potential of HSA-AuNCs/PAH complexes as a function of PAH concentration in solution. HSA-
AuNCs concentration is kept at a concentration of 7.5 M throughout. Vertical red lines indicate the molecular 
ratio between PAH:HSA-AuNCs. Green horizontal line represents PAH zeta potential at pH 7.422. Blue vertical 
line represents HSA-AuNC zeta potential at pH 7.412. 
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protonation (70 %)[33], with the isoelectric point for PAH being pH 10.7[34]. As the overall zeta potential 
becomes positive the HSA-AuNC/PAH complex aggregation size becomes smaller and the fluorescence emission 
enhancement decreases. It is possible that the PAH molecule acts as a linker, joining HSA-AuNC molecules 
together as previously observed for BSA/PAH interactions[35]. As the PAH concentration is increased, more HSA-
AuNCs aggregate together until the ratio is at 1:2 PAH:HSA-AuNCs. Upon adding further PAH, more HSA-AuNC 
molecules have the linker and are unable to aggregate due to electrostatic repulsion of the PAH molecule. A 
change in the overall surface charge due to increased concentration of PAH molecules may also cause stiffening 
of the HSA-AuNC/PAH aggregates formed at larger PAH concentration. Previously, a blue shift in AuNC 
fluorescence emission was observed when doping silica nanoparticles with bovine serum albumin encapsulated 
AuNCs[36], as seen when the Zeta potential becomes positive in this system upon adding PAH at a ratio higher 
than 1:2 to the HSA-AuNC complex. One explanation attributed to the blue shift was the increased stiffness of 
the microenvironment inside the silica nanoparticle where the BSA-AuNCs were seen to reside. 
Conclusions 
 
To conclude, we have found a new method of increasing the brightness of the fluorescence emission from HSA-
AuNCs using a PAH polymer coating. HSA-AuNCs coated in PAH at a molecule ratio of 1:2 resulted in an increase 
of AuNC fluorescence emission intensity of 2.5 times when excited at 290 nm, a smaller increase was observed 
when exciting the AuNC directly at 470 nm. We believe the increase in fluorescence intensity may be due to 
either an enhancement of FRET between TRP  and AuNCs when excited at 290 nm due to a decrease in donor 
acceptor separation and rigidification of the HSA-AuNC by the PAH acting as a linker between HSA-AuNC 
molecules, causing aggregation. The increase in fluorescence intensity when exciting directly at 470 nm arises 
from only the PAH causing aggregation and rigidification of the AuNC. Upon further addition of PAH, the 
fluorescence enhancement was diminished and fluorescence emission returned to normal levels. This may be 
attributed to the reduced aggregation and rigidification resulting from the repulsion between HSA-AuNC/PAH 
molecules as higher ratios of PAH:HSA-AuNC result in increased positive surface charges. It is hoped that this 
study will advance the development of new strategies of improving the brightness of other protein encapsulated 
AuNCs based on either rigidifying the protein/AuNC complex or protecting the complex from the solvent 
environment, which will support the adoption of this new type of fluorophore in biological sensing and imaging 
applications. 
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Highlights 
 
- HSA-AuNCs coated with a PAH polymer (mW 17,500 Da) in different concentrations. 
- 2.5 fold enhancement of fluorescence emission of HSA-AuNCs induced by PAH binding.. 
- Optimum ratio for fluorescence enhancement between HSA-AuNC/PAH is 2:1. 
- Excitation pathway via 290 nm excitation more affected by PAH binding than that via 470 nm 
excitation. 
- Enhancement is likely due to improved FRET efficiency between TRP and AuNCs, and  rigidification 
of the HSA-AuNC complex. 
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